Merck has expanded its Biologics Testing Center in China with 1,500 m2 of new biosafety laboratories. The company is investing a total of €29 million in its testing...
German chemicals, pharmaceuticals and life sciences group Merck, which operates its Healthcare business as EMD Serono in the US and Canada, announced that it plans to...
Merck is the first CTDMO (contract testing, development, and manufacturing organization) to offer an integrated service covering all critical phases of mRNA development...
Lenexa site becomes the largest production facility of dry powder cell culture media in North America.
Abcam, a biotech supplier, has garnered interest from major US life sciences companies Danaher and Agilent as it explores its potential sale. The company has also...
As part of an agreement with China’s Nantong Economic and Technological Development Area (NETDA), Germany’s Merck said it plans to spend €70 million to expand production...
The US Federal Trade Commission’s lawsuit to potentially block the $27.8 merger of Amgen and Horizon Therapeutics is creating heightened concern in the international...
Germany’s Merck is investing €35 million in biosafety testing at its Glasgow and Stirling sites in Scotland. When completed – no date has been given – the company said...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)